Oral bisphosphonate prescription (alendronate, ibandronate, risedronate)
at least 5 years
tests per year, UK, continuous for at least 5 years, then re-assess fracture risk
“Plan to prescribe oral bisphosphonates (alendronate, ibandronate and risedronate) for at least 5 years and then re-assess fracture risk.”
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- At least 10 years for higher-risk people (age 70 or over, hip or vertebral fracture, high-dose glucocorticoids); intravenous zoledronate is given yearly for at least 3 years.
Used in
Kept as evidence; no figure on the platform is computed from it yet.